Pill to Treat Covid-19 Cuts the Risk of Death by Half, Says Merck, Which Will Seek Its Emergency Authorization
(CSU)Medicine has been shown to cut the risk of hospitalization or death by half. The study was done by Merck and Ridgeback Biotherapeutics. If Covid-19 is approved by the FDA, it will be the first oral medicine used to fight viral infections. Merck said that at the interim analysis, molnupiravir reduced the risk of hospitalization […]